made by mixing the fungicide in PDA. Each
compound was homogenate by adding 10 ml sterile
distilled water before it was added to the PDA at 40-
45°C and poured into a sterile petri dish (9 cm
diameter). Fungal mycelia containing PDA medium
(0.5 cm diameter) was placed into the middle of the
petri dish containing PDA plate. The plates were
incubated for 7 days (29°C). The percent reduction
of colony was determine according to Kumar et al.
(2007) as follows:
I
𝑥100%
Where:
I = Percent reduction in growth of fungal,
C = Radial growth (mm) of control,
T = Radial growth (mm) of treatment
2.3 Determination the Resistance of C.
capsici to Benomyl and
Hexaconazole
The resistance of C. capsici to benomyl and
hexaconazole was determined by the method of
repeated subculture which starts from a relative
inhibitory concentration> 90% (very sensitive)
through poisoning of growing media. Isolates from
concentration treatments with I > 90% were sub-
cultured back to new media with the same
concentration. Measurement of the diameter to
determine the (I) is done by the method as in the
previous experiment. Subculture experiments were
stopped when there was a change in the level of
sensitivity of each isolate to the fungicide active
ingredient being tested.
2.4 Determination of C. capsici
Sensitivity Rate for Fungicide
Compounds
The sensitivity level of C. capsici isolates to
fungicide active ingredients was determined based
on the level of relative inhibition (I) based on Kumar
et al (2007) as follows: Very sensitive (I) >90%,
Sensitive : 75% < I ≤ 90%, Moderate resistance:
60% < I ≤ 75%, Resistant: 40% < I ≤ 60%, and Very
resistant: I ≤ 40%.
3 RESULTS AND DISCUSSION
3.1 The Sensitivity of C. Capsici to
Benomyl and Hexaconazole
The sensitivity of C. capsici was determined from
the level of relative inhibition of the fungicide on the
growth of the isolate colony diameter of C. capsici..
The statistical analysis, both single factors, species
or isolates and types of active ingredients,
interactions on the sensitivity level of C. capsici
based on their relative level of resistance, can be
seen in Table 1.
Table 1 shows the fungicide have a significant
effect on C. capsici. Benomil in the 1000 ppm
showed no growth of C. capsici on observations of
2, 4 , 6 , and 8 days. Administration of hexaconazole
in the 4 days treatment of 1000 ppm showed no
growth of C. capsici on observations at day 2, day 4,
day 6 and day 8. This indicates that dose at 1000
ppm inhibit the growth of the pathogenic fungi. It
seem that the growth of C. capsici at dose 750 ppm
was inhibited. According to Andriani and Desta
(2017) benomyl is an active ingredient of systemic
fungicide by specifically targeting to disrupt mitosis
β-tubulin and cell division.
Fungicide with specific compounds showed high
response in inhibiting the growth of the fungal
pathogen. The fungicides prevents fungal infection
by forming a barrier layer on the surface of the plant
(Peres et al. 2004).
3.2 Level of Relative Barriers of C.
capsici Pathogens to Benomyl and
Hexaconazole
The level of relative inhibition of C. capsici
pathogens against benomyl and hexaconazole shows
different results as indicated by the doses and type
of fungicide (Table 2).
Potential development of C. capsici isolates
resistance to fungicide active ingredients was
selected based on relative inhibitory values> 90%.
The test of the potential for resistance development
using (I) > 90% aims to determine the ability of
these isolates to adapt in developing resistance.
Table 2 shows that doses of 750 ppm and 1000 ppm
are the best treatment for the level of relative
pathogenic inhibition.